HRMY logo

Harmony Biosciences Holdings (HRMY) Stock

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

19 August 2020

Indexes:

Not included

Description:

Harmony Biosciences Holdings (HRMY) focuses on developing and commercializing innovative treatments for rare neurological disorders. The company aims to improve the lives of patients with conditions like narcolepsy by providing effective therapies that address unmet medical needs in the healthcare market.

Events Calendar

Earnings

Next earnings date:

Feb 21, 2025

Recent quarterly earnings:

Oct 29, 2024

Recent annual earnings:

Feb 22, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

17 Dec '24 HC Wainwright & Co.
Buy
30 Oct '24 Oppenheimer
Outperform
30 Oct '24 Needham
Buy
30 Oct '24 Cantor Fitzgerald
Overweight
29 Oct '24 Needham
Buy
10 Oct '24 Mizuho
Outperform
02 Oct '24 Needham
Buy
24 Sept '24 Needham
Buy
12 Sept '24 Needham
Buy
10 Sept '24 UBS
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Levi & Korsinsky Announces an Investigation on Behalf of Harmony Biosciences Holdings, Inc. (HRMY) Shareholders Who May Have Been Affected by Fraud
Levi & Korsinsky Announces an Investigation on Behalf of Harmony Biosciences Holdings, Inc. (HRMY) Shareholders Who May Have Been Affected by Fraud
Levi & Korsinsky Announces an Investigation on Behalf of Harmony Biosciences Holdings, Inc. (HRMY) Shareholders Who May Have Been Affected by Fraud
HRMY
accesswire.com20 December 2024

NEW YORK, NY / ACCESSWIRE / December 20, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Harmony Biosciences Holdings, Inc. ("Harmony Biosciences Holdings, Inc.") (NASDAQ:HRMY) concerning possible violations of federal securities laws. On March 28, 2023, Scorpion Capital published a report detailing a string of concerns with Harmony's narcolepsy drug, Wakix (pitolisant).

HARMONY BIOSCIENCES TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
HARMONY BIOSCIENCES TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
HARMONY BIOSCIENCES TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
HRMY
prnewswire.com18 December 2024

PLYMOUTH MEETING, Pa. , Dec. 18, 2024 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced its participation in the 43rd Annual J.P.

Lost Money on Harmony Biosciences Holdings, Inc.(HRMY)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
Lost Money on Harmony Biosciences Holdings, Inc.(HRMY)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
Lost Money on Harmony Biosciences Holdings, Inc.(HRMY)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
HRMY
accesswire.com18 December 2024

NEW YORK, NY / ACCESSWIRE / December 18, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Harmony Biosciences Holdings, Inc. ("Harmony Biosciences Holdings, Inc.") (NASDAQ:HRMY) concerning possible violations of federal securities laws. On March 28, 2023, Scorpion Capital published a report detailing a string of concerns with Harmony's narcolepsy drug, Wakix (pitolisant).

Investors who lost money on Harmony Biosciences Holdings, Inc. should contact Levi & Korsinsky about an ongoing investigation - HRMY
Investors who lost money on Harmony Biosciences Holdings, Inc. should contact Levi & Korsinsky about an ongoing investigation - HRMY
Investors who lost money on Harmony Biosciences Holdings, Inc. should contact Levi & Korsinsky about an ongoing investigation - HRMY
HRMY
accesswire.com17 December 2024

NEW YORK, NY / ACCESSWIRE / December 17, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Harmony Biosciences Holdings, Inc. ("Harmony Biosciences Holdings, Inc.") (NASDAQ:HRMY) concerning possible violations of federal securities laws. On March 28, 2023, Scorpion Capital published a report detailing a string of concerns with Harmony's narcolepsy drug, Wakix (pitolisant).

HRMY ALERT - Levi & Korsinsky Has Commenced an Investigation on Behalf of Harmony Biosciences Holdings, Inc. Shareholders Who Lost Money
HRMY ALERT - Levi & Korsinsky Has Commenced an Investigation on Behalf of Harmony Biosciences Holdings, Inc. Shareholders Who Lost Money
HRMY ALERT - Levi & Korsinsky Has Commenced an Investigation on Behalf of Harmony Biosciences Holdings, Inc. Shareholders Who Lost Money
HRMY
accesswire.com13 December 2024

NEW YORK, NY / ACCESSWIRE / December 13, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Harmony Biosciences Holdings, Inc. ("Harmony Biosciences Holdings, Inc.") (NASDAQ:HRMY) concerning possible violations of federal securities laws. On March 28, 2023, Scorpion Capital published a report detailing a string of concerns with Harmony's narcolepsy drug, Wakix (pitolisant).

Harmony Biosciences Holdings, Inc. Being Investigated on Behalf of Harmony Biosciences Holdings, Inc. Investors. Contact Levi & Korsinsky For Details.
Harmony Biosciences Holdings, Inc. Being Investigated on Behalf of Harmony Biosciences Holdings, Inc. Investors. Contact Levi & Korsinsky For Details.
Harmony Biosciences Holdings, Inc. Being Investigated on Behalf of Harmony Biosciences Holdings, Inc. Investors. Contact Levi & Korsinsky For Details.
HRMY
accesswire.com12 December 2024

NEW YORK, NY / ACCESSWIRE / December 12, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Harmony Biosciences Holdings, Inc. ("Harmony Biosciences Holdings, Inc.") (NASDAQ:HRMY) concerning possible violations of federal securities laws. On March 28, 2023, Scorpion Capital published a report detailing a string of concerns with Harmony's narcolepsy drug, Wakix (pitolisant).

Levi & Korsinsky Investigates Possible Securities Fraud Violations by Harmony Biosciences Holdings, Inc. (HRMY)
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Harmony Biosciences Holdings, Inc. (HRMY)
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Harmony Biosciences Holdings, Inc. (HRMY)
HRMY
accesswire.com11 December 2024

NEW YORK, NY / ACCESSWIRE / December 11, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Harmony Biosciences Holdings, Inc. ("Harmony Biosciences Holdings, Inc.") (NASDAQ:HRMY) concerning possible violations of federal securities laws. On March 28, 2023, Scorpion Capital published a report detailing a string of concerns with Harmony's narcolepsy drug, Wakix (pitolisant).

Did Harmony Biosciences Holdings, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - HRMY
Did Harmony Biosciences Holdings, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - HRMY
Did Harmony Biosciences Holdings, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - HRMY
HRMY
accesswire.com10 December 2024

NEW YORK, NY / ACCESSWIRE / December 10, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Harmony Biosciences Holdings, Inc. ("Harmony Biosciences Holdings, Inc.") (NASDAQ:HRMY) concerning possible violations of federal securities laws. On March 28, 2023, Scorpion Capital published a report detailing a string of concerns with Harmony's narcolepsy drug, Wakix (pitolisant).

Lost Money on Harmony Biosciences Holdings, Inc. (HRMY)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
Lost Money on Harmony Biosciences Holdings, Inc. (HRMY)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
Lost Money on Harmony Biosciences Holdings, Inc. (HRMY)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
HRMY
accesswire.com09 December 2024

NEW YORK, NY / ACCESSWIRE / December 9, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Harmony Biosciences Holdings, Inc. ("Harmony Biosciences Holdings, Inc.") (NASDAQ:HRMY) concerning possible violations of federal securities laws. On March 28, 2023, Scorpion Capital published a report detailing a string of concerns with Harmony's narcolepsy drug, Wakix (pitolisant).

Levi & Korsinsky Investigates Possible Securities Fraud Violations by Harmony Biosciences Holdings, Inc. (HRMY)
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Harmony Biosciences Holdings, Inc. (HRMY)
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Harmony Biosciences Holdings, Inc. (HRMY)
HRMY
accesswire.com06 December 2024

NEW YORK, NY / ACCESSWIRE / December 6, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Harmony Biosciences Holdings, Inc. ("Harmony Biosciences Holdings, Inc.") (NASDAQ:HRMY) concerning possible violations of federal securities laws. On March 28, 2023, Scorpion Capital published a report detailing a string of concerns with Harmony's narcolepsy drug, Wakix (pitolisant).

FAQ

  • What is the primary business of Harmony Biosciences Holdings?
  • What is the ticker symbol for Harmony Biosciences Holdings?
  • Does Harmony Biosciences Holdings pay dividends?
  • What sector is Harmony Biosciences Holdings in?
  • What industry is Harmony Biosciences Holdings in?
  • What country is Harmony Biosciences Holdings based in?
  • When did Harmony Biosciences Holdings go public?
  • Is Harmony Biosciences Holdings in the S&P 500?
  • Is Harmony Biosciences Holdings in the NASDAQ 100?
  • Is Harmony Biosciences Holdings in the Dow Jones?
  • When was Harmony Biosciences Holdings's last earnings report?
  • When does Harmony Biosciences Holdings report earnings?
  • Should I buy Harmony Biosciences Holdings stock now?

What is the primary business of Harmony Biosciences Holdings?

Harmony Biosciences Holdings (HRMY) focuses on developing and commercializing innovative treatments for rare neurological disorders. The company aims to improve the lives of patients with conditions like narcolepsy by providing effective therapies that address unmet medical needs in the healthcare market.

What is the ticker symbol for Harmony Biosciences Holdings?

The ticker symbol for Harmony Biosciences Holdings is NASDAQ:HRMY

Does Harmony Biosciences Holdings pay dividends?

No, Harmony Biosciences Holdings does not pay dividends

What sector is Harmony Biosciences Holdings in?

Harmony Biosciences Holdings is in the Healthcare sector

What industry is Harmony Biosciences Holdings in?

Harmony Biosciences Holdings is in the Biotechnology industry

What country is Harmony Biosciences Holdings based in?

Harmony Biosciences Holdings is headquartered in United States

When did Harmony Biosciences Holdings go public?

Harmony Biosciences Holdings's initial public offering (IPO) was on 19 August 2020

Is Harmony Biosciences Holdings in the S&P 500?

No, Harmony Biosciences Holdings is not included in the S&P 500 index

Is Harmony Biosciences Holdings in the NASDAQ 100?

No, Harmony Biosciences Holdings is not included in the NASDAQ 100 index

Is Harmony Biosciences Holdings in the Dow Jones?

No, Harmony Biosciences Holdings is not included in the Dow Jones index

When was Harmony Biosciences Holdings's last earnings report?

Harmony Biosciences Holdings's most recent earnings report was on 29 October 2024

When does Harmony Biosciences Holdings report earnings?

The next expected earnings date for Harmony Biosciences Holdings is 21 February 2025

Should I buy Harmony Biosciences Holdings stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions